Donald Wuchterl
Directeur/Bestuurslid bij ABEONA THERAPEUTICS INC.
Vermogen: 239 815 $ op 30-04-2024
Actieve functies van Donald Wuchterl
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ABEONA THERAPEUTICS INC. | Directeur/Bestuurslid | 19-04-2021 | - |
Independent Dir/Board Member | 19-04-2021 | - | |
T-Knife Therapeutics, Inc. | Corporate Officer/Principal | - | - |
Loopbaan van Donald Wuchterl
Eerdere bekende functies van Donald Wuchterl
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
AUDENTES THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2016 | 01-01-2021 |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Operationeel Directeur | - | - |
Opleiding van Donald Wuchterl
Fitchburg State University | Masters Business Admin |
Colorado Technical University, Inc. | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 7 |
Operationeel
Corporate Officer/Principal | 2 |
Director/Board Member | 1 |
Independent Dir/Board Member | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ABEONA THERAPEUTICS INC. | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Astellas Gene Therapies, Inc.
Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Astellas Gene Therapies, Inc. is a biotechnology company, which engages in the development and commercialization of gene therapy products for patients with serious and rare diseases caused by single gene defects. The company was founded by Matthew R. Patterson and Thomas J. Schuetz on November 13, 2012 and is headquartered in San Francisco, CA. | Health Technology |
Cytovance Biologics, Inc.
Cytovance Biologics, Inc. BiotechnologyHealth Technology Cytovance Biologics, Inc. operates as a biopharmaceutical contract manufacturing company. It specializes in the production of therapeutic proteins and antibodies from both mammalian cell culture and microbial fermentation. Its services include Cell Line Selection, Cell Culture, Recovery and Purification, Analytical development, Troubleshooting Existing Processes, Final Product Fill and Finish, Technology Transfer, Microbial Fermentation, Purification, Cell banking and storage, and Project management. The company was founded in 2003 and is headquartered in Oklahoma City, OK. | Health Technology |
T-Knife Therapeutics, Inc. |
- Beurs
- Insiders
- Donald Wuchterl
- Ervaring